# Glutamine Supplement in MELAS (Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like Episodes) Syndrome

> **NCT04948138** · NA · COMPLETED · sponsor: **Jesús González de la Aleja Tejera** · enrollment: 9 (actual)

## Conditions studied

- MELAS Syndrome

## Interventions

- **DIETARY_SUPPLEMENT:** Glutamine oral supplementation

## Key facts

- **NCT ID:** NCT04948138
- **Lead sponsor:** Jesús González de la Aleja Tejera
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-28
- **Primary completion:** 2021-09-09
- **Final completion:** 2021-10-06
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2022-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04948138

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04948138, "Glutamine Supplement in MELAS (Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like Episodes) Syndrome". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT04948138. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*